traZODONE Hydrochloride Tablets, USP, 100mg, 1,000 Tablets, Rx only
Recalled by Zydus Pharmaceuticals (USA) Inc
Class III — least serious
Using this product is not likely to cause health problems, but it breaks an FDA rule (for example, a labeling or packaging issue).
Zydus Pharmaceuticals (USA) Inc has recalled traZODONE Hydrochloride Tablets, USP, 100mg, 1,000 Tablets, Rx only, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on January 7, 2026 and was initiated on December 19, 2025. It is classified as a Class III recall, which means using this product is not likely to cause health problems, but it breaks an FDA rule (for example, a labeling or packaging issue).
Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.
What was recalled?
This recall covers traZODONE Hydrochloride Tablets, USP, 100mg, 1,000 Tablets, Rx only, with approximately 2,136 1000-count bottles affected. The company behind the recall is Zydus Pharmaceuticals (USA) Inc, based in Pennington, NJ. The FDA describes the product as: “traZODONE Hydrochloride Tablets, USP, 100mg, 1,000 Tablets, Rx only, Manufactured by: Zydus Lifesciences Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-806-10”
Why was traZODONE Hydrochloride Tablets, USP, 100mg, 1,000 Tablets, Rx only recalled?
According to the FDA, the stated reason for the recall is: “Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface.”
What should you do?
If you think you may have bought traZODONE Hydrochloride Tablets, USP, 100mg, 1,000 Tablets, Rx only, compare it against the product description and identifying codes (Lot # EA00237A, Exp Date: 04/30/2027) before using it. This recall is currently listed as ongoing.
The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact Zydus Pharmaceuticals (USA) Inc or your local health authority.
About this recall
This recall was distributed in NJ. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.
Full recall details
- Status
- Ongoing
- Date reported
- January 7, 2026
- Recall started
- December 19, 2025
- Distributed in
- NJ
What you can do
Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.
Quick answers
Why was traZODONE Hydrochloride Tablets, USP, 100mg, 1,000 Tablets, Rx only recalled?+
According to the FDA: Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on…
How serious is this recall?+
Class III — least serious. Using this product is not likely to cause health problems, but it breaks an FDA rule (for example, a labeling or packaging issue).
What should I do if I have traZODONE Hydrochloride Tablets, USP, 100mg, 1,000 Tablets, Rx only?+
Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.
Opens the U.S. Food and Drug Administration (FDA) data for this recall.
Recall number: D-0247-2026. Information last synced from the FDA on July 6, 2026.